Open Actively Recruiting

Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial

About

Brief Summary

This clinical trial tests an individually tailored, supervised, remote exercise intervention to improve physical function for stage I-III gastroesophageal cancer survivors. Modern treatments for gastroesophageal cancer are effective at treating the cancer but are often aggressive, can be difficult for patients to tolerate, and can lead to significant debilitation and a loss of independence. Exercise is one promising intervention that could improve physical function in patients with gastroesophageal cancer after finishing systemic treatment. Home based exercise interventions in patients with cancer during and after chemotherapy can improve fatigue and function. An individually tailored, supervised, remote exercise intervention may improve physical function for stage I-III gastroesophageal cancer survivors.

Primary Purpose
The main objective of the intervention(s) being evaluated by the clinical trial. Learn more
Supportive care
Study Type
The nature of the investigation or investigational use for which clinical study information is being submitted. Learn more
Interventional
Phase
Pilot/Feasibility

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
N/A

Inclusion Criteria:

  • Adults ≥ 18 years old at the start of study treatment
  • Diagnosis of early-stage (Stage I, II, III) esophageal, gastroesophageal junction, or gastric cancer. Histology can be adenocarcinoma, squamous cell carcinoma, or poorly differentiated carcinoma
  • Treated with at least one systemic therapy (chemotherapy or immunotherapy) and within 12 months of completing curative intent gastroesophageal cancer (GEC) treatment
  • Have evidence of physical function impairment, defined as a SPPB score of < 12) at baseline
  • Ability to understand English and the willingness to sign a written informed consent document

Exclusion Criteria:

  • Patients with stage I disease who underwent endoscopic resection or surgery alone without perioperative systemic therapy
  • Patients with stage IV disease or unresectable locally advanced disease taking a palliative treatment approach without a clearly defined end of treatment
  • Patients currently receiving ongoing systemic therapy for GEC or another malignancy
  • Patients who are unable to provide informed consent
  • Any other condition or pre-existing co-morbidity that would, in the Investigator's judgment, contraindicate the participation in the study due to safety concerns with study procedures
  • Currently participating in another exercise intervention research study seeking to improve functional status, alleviate frailty, muscle strength, exhaustion/fatigue, or cognitive function
Study Stats
Protocol No.
25-0954
Category
Esophageal Cancer
Stomach Cancer
Principal Investigator
Dr. Jingran Ji
Jingran Ji, MD
Hematology Oncology
Jingran Ji, MD
Contact
  • Jingran Ji
Location
  • UCLA Westwood
For Providers
NCT No.
NCT07439484
For detailed technical eligibility, visit ClinicalTrials.gov.